Agenda and minutes

Venue: Committee Room 3 - Senedd. View directions

Contact: Llinos Dafydd 

Items
Expected timing No. Item

1.

Introductions, apologies and substitutions

Minutes:

1.1 Apologies were received from Mick Antoniw and Darren Millar.  Gwyn R Price attended as a substitute for Mick Antoniw.

(09.30 - 10.25)

2.

Inquiry into the contribution of community pharmacy to health services in Wales - Evidence from BMA Cymru Wales, the Dispensing Doctors' Association and the Royal College of General Practitioners

HSC(4)-09-11 paper 1- BMA Cymru Wales

          Dr David Bailey, Chair, General Practice Committee Wales

Dr Philip White, General Practice Committee Wales Negotiator

 

HSC(4)-09-11 paper 2 – The Dispensing Doctors’ Association

          Dr David Baker, Chief Executive

 

HSC(4)-09-11 paper 3 – Royal College of General Practitioners

          Dr Paul Myers, Chair Elect

 

Break 10.25 – 10.30

Supporting documents:

Minutes:

2.1 The witnesses responded to questions from members of the Committee on the contribution of community pharmacy to health services in Wales.

 

2.2 The Committee requested a map detailing information on the locations of dispensing practices in rural areas.

 

2.3 Dr Myers agreed to share with the Committee a paper on the pilot study carried out by Aneurin Bevan Health Board on the use of Medicines Use Reviews by community pharmacists.

(10.30 - 11.30)

3.

Inquiry into Stroke Risk Reduction - Evidence from the Minister for Health and Social Services

HSC(4)-09-11 paper 4

          Lesley Griffiths AM, Minister for Health and Social Services

Dr Tony Jewell, Chief Medical Officer

Chris Tudor-Smith, Head of Health Improvement Division

Supporting documents:

Minutes:

3.1 The Minister for Health and Social Services, the Chief Medical Officer and Dr Chris Jones, responded to questions from members of the Committee on stroke risk reduction.

(11.30 - 12.15)

4.

Inquiry into the contribution of community pharmacy to health services in Wales - Evidence from NHS representatives

HSC(4)-09-11 paper 5 – Hywel Dda Health Board

HSC(4)-09-11 paper 6 – Betsi Cadwaladr University Health Board

HSC(4)-09-11 paper 7 – Cwm Tâf Health Board

 

          Chris Martin, Chair, Hywel Dda Health Board

Berwyn Owen, Betsi Cadwaladr University Health Board and Director of the National Medicines Management Programme

Bernadine Rees, Executive Director of Primary, Community and Mental Health, Cwm Tâf Health Board

Supporting documents:

Minutes:

4.1 The witnesses responded to questions from members of the Committee on the contribution of community pharmacy to health services in Wales.

5.

Papers to note

Inquiry into Stroke Risk Reduction

 

HSC(4)-09-11 paper 8

Information from the Association of Directors of Social Services

 

HSC(4)-09-11 paper 9

Information from the Older People’s Commissioner for Wales

 

HSC(4)-09-11 paper 10

Additional information from Health Board representatives

 

HSC(4)-09-11 paper 11

Response from the Royal Pharmaceutical Society

 

Inquiry into the contribution of community pharmacy to health services in Wales

 

HSC(4)-09-11 paper 12

Additional information from the Royal Pharmaceutical Society

 

HSC(4)-09-11 paper 13 – Paper not received

Additional information from Community Pharmacy Wales

 

HSC(4)-09-11 paper 14

Additional information from Public Health Wales

 

Scrutiny of the Older People’s Commissioner for Wales’ Annual Report

 

HSC(4)-09-11 paper 15

Additional information from the Older People’s Commissioner for Wales

Supporting documents:

Minutes:

5.1 The Committee agreed to hold an evidence session with representatives from Community Pharmacy Scotland and the Royal Pharmaceutical Society Scotland via video conference on 24 November as part of the inquiry into community pharmacy.

 

5.2 The Committee agreed to hold an informal training session on legislation scrutiny on 10 November and that each member could allow a member of their staff to attend.

Transcript